CAMK2G and diabetes mellitus: Interestingly, a CaMKII inhibitor, KN-93, was also able to prevent the development of abnormal vascular reactivity in a rat model of diabetes and hypertension (Yousif et al., 2008) implying that NO production might also involve CaMKII-independent pathways in such pathologies.